These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance. Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773 [TBL] [Abstract][Full Text] [Related]
4. Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Sahota SS; Forconi F; Ottensmeier CH; Provan D; Oscier DG; Hamblin TJ; Stevenson FK Blood; 2002 Aug; 100(4):1505-7. PubMed ID: 12149241 [TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences. Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance. Martín-Jiménez P; García-Sanz R; Balanzategui A; Alcoceba M; Ocio E; Sanchez ML; González M; San Miguel J Haematologica; 2007 May; 92(5):635-42. PubMed ID: 17488687 [TBL] [Abstract][Full Text] [Related]
7. Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors. Varettoni M; Zibellini S; Capello D; Arcaini L; Rossi D; Pascutto C; Rattotti S; Mangiacavalli S; Pochintesta L; Gotti M; Gaidano G; Cazzola M Leuk Lymphoma; 2013 Nov; 54(11):2485-9. PubMed ID: 23442064 [TBL] [Abstract][Full Text] [Related]
9. Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation. Walsh SH; Laurell A; Sundström G; Roos G; Sundström C; Rosenquist R Leuk Res; 2005 Jul; 29(7):729-34. PubMed ID: 15927667 [TBL] [Abstract][Full Text] [Related]
10. Sequence and expression analyses of mu and delta transcripts in patients with Waldenström's macroglobulinemia. Shiokawa S; Suehiro Y; Uike N; Muta K; Nishimura J Am J Hematol; 2001 Nov; 68(3):139-43. PubMed ID: 11754393 [TBL] [Abstract][Full Text] [Related]
11. Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor? Kriangkum J; Taylor BJ; Reiman T; Belch AR; Pilarski LM Clin Lymphoma; 2005 Mar; 5(4):217-9. PubMed ID: 15794851 [TBL] [Abstract][Full Text] [Related]
12. Frequent somatic mutations in D and/or JH segments of Ig gene in Waldenström's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome but not in common CLL. Aoki H; Takishita M; Kosaka M; Saito S Blood; 1995 Apr; 85(7):1913-9. PubMed ID: 7703494 [TBL] [Abstract][Full Text] [Related]
13. Intraclonal homogeneity of clonotypic immunoglobulin M and diversity of nonclinical post-switch isotypes in multiple myeloma: insights into the evolution of the myeloma clone. Taylor BJ; Pittman JA; Seeberger K; Mant MJ; Reiman T; Belch AR; Pilarski LM Clin Cancer Res; 2002 Feb; 8(2):502-13. PubMed ID: 11839670 [TBL] [Abstract][Full Text] [Related]
14. I.29 lymphoma cells express a nonmutated VH gene before and after H chain switch. Klein D; Nietupski J; Sirlin S; Stavnezer J J Immunol; 1988 Mar; 140(5):1676-84. PubMed ID: 3126234 [TBL] [Abstract][Full Text] [Related]
15. V(H) gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events. Sahota SS; Garand R; Mahroof R; Smith A; Juge-Morineau N; Stevenson FK; Bataille R Blood; 1999 Aug; 94(3):1070-6. PubMed ID: 10419900 [TBL] [Abstract][Full Text] [Related]
16. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316 [TBL] [Abstract][Full Text] [Related]
17. Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machinery. Kriangkum J; Taylor BJ; Strachan E; Mant MJ; Reiman T; Belch AR; Pilarski LM Blood; 2006 Apr; 107(7):2920-7. PubMed ID: 16317092 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118 [TBL] [Abstract][Full Text] [Related]
19. Malignant transformation in IgM monoclonal gammopathy of undetermined significance. Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132 [TBL] [Abstract][Full Text] [Related]
20. Genetics and cytogenetics of Waldenstrom's macroglobulinemia. Schop RF; Fonseca R Semin Oncol; 2003 Apr; 30(2):142-5. PubMed ID: 12720124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]